Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Volume 314, Issue 3, Pages L406-L420
Publisher
American Physiological Society
Online
2017-11-23
DOI
10.1152/ajplung.00223.2017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ceramide Signaling and Metabolism in Pathophysiological States of the Lung
- (2016) Irina Petrache et al. Annual Review of Physiology
- Acid ceramidase and the treatment of ceramide diseases: The expanding role of enzyme replacement therapy
- (2016) Edward H. Schuchman BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Role of Sphingolipids in the Pathobiology of Lung Inflammation
- (2015) Riccardo Ghidoni et al. MEDIATORS OF INFLAMMATION
- New insights into the organ-specific adverse effects of fumonisin B1: comparison between lung and liver
- (2014) Nicolas Loiseau et al. ARCHIVES OF TOXICOLOGY
- Sphingolipids in Lung Growth and Repair
- (2014) Jeroen Tibboel et al. CHEST
- Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa
- (2014) Y. Pewzner-Jung et al. EMBO Molecular Medicine
- Systemic ceramide accumulation leads to severe and varied pathological consequences
- (2013) Abdulfatah M. Alayoubi et al. EMBO Molecular Medicine
- TNF-Induced Death Signaling Triggers Alveolar Epithelial Dysfunction in Acute Lung Injury
- (2013) B. V. Patel et al. JOURNAL OF IMMUNOLOGY
- Ceramide Synthases Expression and Role of Ceramide Synthase-2 in the Lung: Insight from Human Lung Cells and Mouse Models
- (2013) Irina Petrache et al. PLoS One
- Monocyte Chemoattractant Protein 1 Regulates Pulmonary Host Defense via Neutrophil Recruitment during Escherichia coli Infection
- (2011) Gayathriy Balamayooran et al. INFECTION AND IMMUNITY
- The role of sphingolipids in respiratory disease
- (2011) Yang Yang et al. Therapeutic Advances in Respiratory Disease
- Functions of Type II Pneumocyte-Derived Vascular Endothelial Growth Factor in Alveolar Structure, Acute Inflammation, and Vascular Permeability
- (2010) Marco Mura et al. AMERICAN JOURNAL OF PATHOLOGY
- Vascular Barrier Regulation by PAF, Ceramide, Caveolae, and NO - an Intricate Signaling Network with Discrepant Effects in the Pulmonary and Systemic Vasculature
- (2010) Wolfgang M. Kuebler et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Respiratory disease in Niemann-Pick type C2 is caused by pulmonary alveolar proteinosis
- (2009) M Griese et al. CLINICAL GENETICS
- Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase
- (2009) Y. Yang et al. EUROPEAN RESPIRATORY JOURNAL
- Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions
- (2009) Peter Vogel et al. PLoS One
- Sphingolipids in the Lungs
- (2008) Stefan Uhlig et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Regulation of vascular permeability by sphingosine 1-phosphate
- (2008) Lichun Wang et al. MICROVASCULAR RESEARCH
- Principles of bioactive lipid signalling: lessons from sphingolipids
- (2008) Yusuf A. Hannun et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search